Accurate International

Accurate International Biotechnology (trading as ACCURATE, 广州创芯国际生物科技有限公司) is a Guangzhou, China biotechnology company founded in 2018 that builds the full industry chain around organoid technology for cancer precision medicine, new drug research and regenerative medicine. Its products are wet-lab reagents, instruments and consumables rather than software: Accuroid organoid culture media, the AccuArray microarray organoid chip, the AOMF microfluidic organoid chip and 3D bioprinter, the AccuLumi high-throughput chemiluminescence detector, and Accuauto automated organoid culture workstations. On top of those it sells services — BUDcare and BUDhealth patient-derived tumor organoid drug-sensitivity testing delivered through Guangzhou Chuangxin Independent Clinical Laboratory, and organoid-model new-drug R&D services for pharma — and reports 32,000+ organoid cultures, 5,000+ tumor organoid models, 200+ clinical collaborators and 100+ filed patents. It holds subsidiaries in Beijing, Shanghai and Macau plus a European entity, and has raised Pre-A (2020), Series A (2021), a 100M RMB Pre-B (2022) and a Series B (2024). ACCURATE describes internal digital assets — the AOD Tronchip organoid database launched in 2023 and a cancer "deep-thinking" AI model built in 2024 — but publishes no developer portal, API reference, SDK, CLI, status page or public GitHub organization, and no OpenAPI, AsyncAPI, GraphQL, MCP or A2A agent-card surface was found on any host it operates.

Accurate International is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Life Sciences, Precision Medicine, and Oncology.

Accurate International’s developer surface includes engineering blog and 3 more developer resources.

🌐 Visit website 📡 Source on GitHub
4.5/100 minimal Agent 0/100 human only Full breakdown ↓
scored 2026-09-06 · rubric v0.19.0
0 APIs
CompanyBiotechnologyLife SciencesPrecision MedicineOncologyOrganoidsLaboratory InstrumentsClinical DiagnosticsDrug DiscoveryChina

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-09-06 · rubric v0.19.0
Composite quality — 4.5/100 · minimal
Contract Quality 0.0 / 21
Developer Ergonomics 0.4 / 17
Access Clarity 0.0 / 17
Operational Transparency 0.0 / 11
Contract Governance 0.0 / 10
Discoverability 4.9 / 9
Regulatory Posture 1.1 / 15
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 10
Documented Reversibility 0 / 6
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
A2A Agent Card 0 / 8
Dry-Run / Simulate Mode 0 / 4
Delegated User Identity 0 / 6
Protected Resource Metadata 0 / 5
Registration Without a Human 0 / 6
Agentic Commerce Well-Known Document 0 / 5
Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.
The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. Every facet and dimension name above is a link: it opens that measurement's own page — what it means, the exact checks that feed it, how the whole catalog distributes on it, and the providers at the top of it. This rating is computed from github.com/api-evangelist/accurateinternational: open an issue to ask a question, or submit a pull request to add artifacts. Submit an artifact on GitHub — free → Manage your own listing — the Influence plan, $499/mo →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Accurateinternational Domain Security

TLSv1.3 · HSTS

SECURITY

Resources

Agent Surfaces 1

MCP servers, agent skills, and machine-readable catalogs

LLMsTxt
LLMsTxt

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: accurateinternational
name: Accurate International
description: 'Accurate International Biotechnology (trading as ACCURATE, 广州创芯国际生物科技有限公司) is a Guangzhou, China biotechnology
  company founded in 2018 that builds the full industry chain around organoid technology for cancer precision medicine, new
  drug research and regenerative medicine. Its products are wet-lab reagents, instruments and consumables rather than software:
  Accuroid organoid culture media, the AccuArray microarray organoid chip, the AOMF microfluidic organoid chip and 3D bioprinter,
  the AccuLumi high-throughput chemiluminescence detector, and Accuauto automated organoid culture workstations. On top of
  those it sells services — BUDcare and BUDhealth patient-derived tumor organoid drug-sensitivity testing delivered through
  Guangzhou Chuangxin Independent Clinical Laboratory, and organoid-model new-drug R&D services for pharma — and reports 32,000+
  organoid cultures, 5,000+ tumor organoid models, 200+ clinical collaborators and 100+ filed patents. It holds subsidiaries
  in Beijing, Shanghai and Macau plus a European entity, and has raised Pre-A (2020), Series A (2021), a 100M RMB Pre-B (2022)
  and a Series B (2024). ACCURATE describes internal digital assets — the AOD Tronchip organoid database launched in 2023
  and a cancer "deep-thinking" AI model built in 2024 — but publishes no developer portal, API reference, SDK, CLI, status
  page or public GitHub organization, and no OpenAPI, AsyncAPI, GraphQL, MCP or A2A agent-card surface was found on any host
  it operates.'
url: https://raw.githubusercontent.com/api-evangelist/accurateinternational/refs/heads/main/apis.yml
image: https://en.bio-accurate.com/dist/images/logo.png
x-type: company
x-source: harvest:secondary-market
x-harvest-source-url: https://equityzen.com/company/accurateinternational
x-venue-listings:
- venue: EquityZen
  url: https://equityzen.com/company/accurateinternational
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.20'
created: '2026-09-06'
modified: '2026-09-06'
tags:
- Company
- Biotechnology
- Life Sciences
- Precision Medicine
- Oncology
- Organoids
- Laboratory Instruments
- Clinical Diagnostics
- Drug Discovery
- China
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/accurateinternational-domain-security.yml
- type: Website
  url: https://en.bio-accurate.com/
- type: Blog
  url: https://en.bio-accurate.com/news/dynamic/
- type: LLMsTxt
  url: llms/accurateinternational-llms.txt
x-enrichment:
  date: '2026-09-06'
  status: minimal
  artifacts_added: 3
  pass: local-v3
x-coverage:
  state: none
  reason: no-developer-program
  detail: ACCURATE is a Guangzhou organoid biotech selling culture media, microfluidic chips, detectors and clinical drug-sensitivity
    testing — its only digital assets (the AOD Tronchip organoid database and a 2024 cancer AI model) are internal R&D tooling
    with no public interface, and bio-accurate.com has no developer section, no /.well-known/ documents on either host, and
    no api/db/data/developer subdomain in DNS.
  evidence:
  - url: https://en.bio-accurate.com/
    status: 200
  - url: https://en.bio-accurate.com/.well-known/agent-card.json
    status: 404
  - url: https://en.bio-accurate.com/.well-known/api-catalog
    status: 404
  - url: https://www.bio-accurate.com/.well-known/security.txt
    status: 404
  checked: '2026-09-06'

Work with this as data

Every provider here is available over the APIs.io API and to AI agents over MCP.

MCP server

One button, every client — Claude, Cursor, VS Code and the rest.

https://apis.io/mcp

Tools for providers

9 MCP tools reach this
  • find_providersBrowse and filter every provider in the catalog.
  • get_provider_artifactsEvery artifact this provider publishes, grouped by type.
  • get_provider_operationsEvery operation across all of their OpenAPIs — one call instead of parsing every spec.
  • get_provider_toolsEvery MCP tool they ship, with the operation each wraps.
  • get_provider_evidenceHow each part of their score was established. Free — the basis for a claim should not sit behind it.
  • get_provider_ratingPRO — composite, band, trend and facet scores.
  • apis_io_searchSTART HERE — APIs, providers and tags for one query, each with its total.
  • resolveTurn a domain, URL or GitHub org into the provider it belongs to.
  • find_cohortsEvery scored population of providers in the catalog.
All 92 tools →

Call it yourself

curl for this page
This provider 
curl "https://apis.io/api/v1/providers/accurateinternational"
All providers 
curl "https://apis.io/api/v1/providers?limit=25"
Every operation they expose 
curl "https://apis.io/api/v1/providers/accurateinternational/operations?limit=25"
How their score was established 
curl "https://apis.io/api/v1/providers/accurateinternational/evidence"

Discovery needs no key. Ratings and market analysis are Pro.

Get an API key

Free tier, no email required.

GitHub Google LinkedIn

A second provider on the same verified email joins the account you already have.